Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reagent Proteins is a specialized provider of high-purity recombinant proteins and enzymes tailored for the biopharmaceutical and life sciences sectors. Operating as a division of Pfanstiehl, the company focuses on supplying critical raw materials and reagents used in the purification and manufacturing of biologics, including monoclonal antibodies. Their core product line features affinity ligands such as Protein A, Protein G, and Protein L, alongside high-activity nucleases for DNA and RNA removal. Reagent Proteins distinguishes itself through a commitment to animal-free production and GMP-compliant manufacturing, ensuring that its products meet the rigorous quality standards required for clinical and commercial bioprocessing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reagent Proteins.